ArticleNature reviews. Clinical oncology2016
Prostate cancer: Personalized risk - stratified screening or abandoning it altogether?
Article in Nature reviews. Clinical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Advances of Zinc Signaling Studies in Prostate Cancer.International journal of molecular sciences · 2020Review
- Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management.Nature reviews. Urology · 2019Review
- Prostate cancer screening-when to start and how to screen?Translational andrology and urology · 2018Review
- Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017.Current opinion in urology · 2017Review
- The Metabolic Phenotype of Prostate Cancer.Frontiers in oncology · 2017Review
- What's new in screening in 2015?Current opinion in urology · 2016Review
- The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments.Nature reviews. Clinical oncology · 2016Article
- The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments.Nature reviews. Clinical oncology · 2016Article
- Identifying the role of apolipoprotein A-I in prostate cancer.Asian journal of andrologyArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
26831183What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.